Hypoxic hepatitis: Underlying conditions and risk factors for mortality in critically ill patients

Intensive Care Medicine

Volumn 35, Issue 8, 2009, Pages 1397-1405

  Fuhrmann, Valentin ^a   Kneidinger, Nikolaus ^a   Herkner, Harald ^a   Heinz, Gottfried ^a   Nikfardjam, Mariam ^a   Bojic, Anja ^a   Schellongowski, Peter ^a   Angermayr, Bernhard ^a   Kitzberger, Reinhard ^a   Warszawska, Joanna ^a   Holzinger, Ulrike ^a   Schenk, Peter ^a   Madl, Christian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Hypoglycemia; Ischemic hepatitis; Risk factors; Shock liver

Indexed keywords

ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; LACTIC ACID;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CARDIOMYOPATHY; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CRITICALLY ILL PATIENT; DISEASE DURATION; ENZYME BLOOD LEVEL; FEMALE; HEART DISEASE; HEART OUTPUT; HEMORRHAGIC SHOCK; HEPATITIS; HUMAN; HUMAN TISSUE; HYPERTRANSLUCENT LUNG; HYPOGLYCEMIA; HYPOXIA; HYPOXIC HEPATITIS; INTENSIVE CARE UNIT; LABORATORY TEST; LIVER CIRRHOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERICARDIAL EFFUSION; RESUSCITATION; SEPTIC SHOCK; SLEEP APNEA SYNDROME; UNIVERSITY HOSPITAL; VALVULAR HEART DISEASE;

AGED; ANOXIA; AUSTRIA; CRITICAL ILLNESS; FEMALE; HEPATITIS; HOSPITALS, UNIVERSITY; HUMANS; HYPOGLYCEMIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SHOCK, SEPTIC;

EID: 67650951164     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-009-1508-2     Document Type: Article

References (37)

1. L Kramer B Jordan W Druml P Bauer PG Metnitz 2007 Incidence and prognosis of early hepatic function in critically ill patients-a prospective multicenter study Crit Care Med 35 1099 1104
2. V Fuhrmann C Madl C Mueller U Holzinger R Kitzberger G Funk P Schenk 2006 Hepatopulmonary syndrome in patients with hypoxic hepatitis Gastroenterology 131 69 75
3. American Gastroenterological Association 2002 American Gastroenterological Association medical position statement: evaluation of liver chemistry tests Gastroenterology 123 1364 1366
4. J Henrion M Schapira R Luwaert L Colin A Delannoy FR Heller 2003 Hypoxic hepatitis. Clinical and hemodynamic study in 142 consecutive cases Medicine (Baltimore) 82 392 406
5. MW Whitehead ND Hawkes I Hainsworth JG Kingham 1999 A prospective study of the causes of notably raised aspartate aminotransferase of liver origin Gut 45 129 133
6. RD Johnson C O?Connor RM Kerr 1995 Extreme serum elevations of aspartate aminotransferase Am J Gastroenterol 90 1244 1245
7. PR Gibson F Dudely 1984 Ischemic hepatitis: clinical features, diagnosis and prognosis Aust N Z J Med 14 822 825
8. S Fuchs V Bogomolski-Yahalom O Paltiel Z Ackerman 1998 Ischemic hepatitis. Clinical and laboratory observations of 34 patients J Clin Gastroenterol 26 183 186
9. R Birrer Y Takuda T Takara 2007 Hypoxic hepatopathy: pathophysiology and prognosis Intern Med 46 1063 1070
10. RK Seeto B Fenn DC Rockey 2000 Ischemic hepatitis: clinical presentation and pathogenesis Am J Med 109 109 113
11. E Rivers B Nguyen S Havstad J Ressler A Muzzin B Knoblich E Peterson M Tomlanovich Early Goal-Directed Therapy Collaborative Group 2001 Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 1368 1377
12. A Kumar D Roberts KE Wood B Light JE Parillo S Sharma S Suppes D Feinstein S Zanotti L Taiberg D Gurka A Kumar M Cheang 2006 Duration of hypotension prior to initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 34 1589 1596
13. S Topalian F Ginsberg JE Parrillo 2008 Cardiogenic shock Crit Care Med 36 Suppl S66 S74
14. B Schneeweiss J Pammer K Ratheiser B Schneider C Madl L Kramer A Kranz P Ferenci W Druml G Grimm 1993 Energy metabolism in acute hepatic failure Gastroenterology 105 1515 1521
15. PE Hickman J Potter 1990 Mortality associated with ischemic hepatitis Aust N Z J Med 20 32 34
16. RJ Goldberg N Samad J Yarzebski J Gurwitz C Bigelow JM Gore 1999 Temporal trends in cardiogenic shock complicating acute myocardial infarction N Engl J Med 340 1162 1168
17. RM Califf J Bengtson 1994 Cardiogenic shock N Engl J Med 330 1724 1730
18. American College of Chest Physicians (Society of Critical Care Medicine Consensus Conference) 1992 Definition of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med 20 864 874
19. G Van den Berghe P Wouters F Weekers C Verwaest F Bruyninckx M Schetz D Vlasselaers P Ferdinande P Lauwers R Bouillon 2001 Intensive insulin therapy in critically ill patients N Engl J Med 345 1359 1367
20. FM Brunkhorst C Engel F Bloos A Meier-Hellmann M Ragaller N Weiler O Moerer M Gruendling M Oppert S Grond D Olthoff U Jaschinski S John R Rossaint T Welte M Schaefer P Kern E Kuhnt M Kiehntopf C Hartog C Natanson M Loeffler K Reinhart German Competence Network Sepsis (SepNet) 2008 Intensive insulin therapy and pentastarch resuscitation in severe sepsis N Engl J Med 358 125 139
21. J Henrion P Minette L Colin M Schapira A Delannoy FR Heller 1999 Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: A case-controlled, hemodynamic study of 17 consecutive cases Hepatology 29 427 433
22. M Malinchoc P Kamath FD Gordon CJ Peine J Rank PC ter Borg 2000 A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts Hepatology 31 864 871
23. J Polson WM Lee American Association for the Study of Liver disease 2005 AASLD position paper: the management of acute liver failure Hepatology 41 1179 1197
24. C Peralta J Perales R Bartrons C Mitchell H Gilgenkrantz C Xaus N Prats N Fernandez E Gelpi J Panes J Rosello-Catafau 2002 The combination of ischemic preconditioning and liver Bcl-2 over expression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion Am J Pathol 160 2111 2122
25. VG Nielsen S Tan MS Baird PN Samuelson AT McCammon DA Parks 1997 Xanthine oxidase mediates myocardial injury after hepatoenteric ischemia-reperfusion Crit Care Med 25 1044 1050
26. G Van den Berghe A Wilmer G Hermans W Meersseman PJ Wouters I Milants E Van Wijngaerden H Bobbaers R Bouillon 2006 Intensive insulin therapy in the medical ICU N Engl J Med 354 449 461
27. RT Stravitz A Kramer T Davern O Shaikh SH Caldwell RL Mehta AT Blei RJ Fontana BM McGuire L Rossaro AD Smith WM Lee Acute Liver Failure Study Group 2007 Intensive care of patients with acute liver failure: Recommendations of the U.S. Acute Liver Failure Study Group Crit Care Med 35 2498 2508
28. G Dunn P Hayes KJ Breen 1973 The liver in congestive heart failure: a review Am J Med Sci 265 174 189
29. J Henrion O Descamps R Luwaert M Schapira A Parfonry F Heller 1994 Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow J Hepatol 21 696 703
30. R Myers R Cerini R Sayegh R Moreau C Degott D Lebrec SS Lee 2003 Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations Hepatology 37 393 400
31. S Sakka N von Hout 2006 Relation between indocyanine green clearance (ICG) plasma disappearance rate and ICG blood clearance in critically ill patients Intensive Care Med 32 766 769
32. S Sakka H Koeck A Meier-Hellmann 2004 Measurement of indocyanine green plasma disappearance rate by two different dosages Intensive Care Med 30 506 509
33. S Sakka K Reinhart A Meier-Hellmann 2000 Comparison of invasive and noninvasive measurements of indocyanine green plasma disappearance rate in critically ill patients with mechanical ventilation and stable hemodynamics Intensive Care Med 26 1553 1556
34. N Kneidinger V Fuhrmann R Kitzberger J Warszawska U Holzinger G Lindner P Schenk G Locker G Heinz C Madl 2007 Intensive Care Med 33 2 0188
35. JL Vincent R Moreno J Takala S Willatts A De Mendoca H Bruining CK Reinhart PM Suter LG Thijs 1996 The SOFA (sepsis-related organ assessment) score to describe organ dysfunction/failure Intensive Care Med 22 707 710
36. C Aninat P Seguin P-N Descheemaeker F Morel Y Malledant A Guillouzo 2008 Catecholamines induce an inflammatory response in human hepatocytes Crit Care Med 36 848 854
37. F Carvalho F Remiao ME Soares R Catarino G Queiroz ML Bastos 1997 d-Amphetamine-induced hepatotoxicity: possible contribution of catecholamines and hyperthermia to the effect studied in isolated rat hepatocytes Arch Toxicol 71 429 436